Explore the latest news on 23andMe as a U.S. judge approves its sale amid privacy concerns and consumer issues.

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to a nonprofit led by the company’s co-founder and former CEO, Anne Wojcicki.

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a higher bid.

This was the stock's third consecutive day of gains.

The NFL asked rookies to paint their new team logos from memory, and some of them aren't half bad.

Fabian Muhly is Partner at Leo & Muhly Cyber Advisory and founder of DRMUHLY, an initiative promoting cyber risk resilience through wellbeing. Holding a PhD in criminology, his consulting and ...

Global manufacturers are constantly revamping their network of plants. Surviving over the long term for a factory—especially one located in a high-cost country—can be extremely difficult. But ...

ROME — Spyware from a U.S.-backed Israeli company was used to target the phones of at least three prominent journalists in Europe, two of whom are editors at an investigative news site in Italy ...

As our own Jamie Kennedy pointed out, it took the featured group 71 minutes to take on three holes to start Friday’s second round of the 2025 U.S. Open. You stretch that out to 18 holes, and we ...

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against Regeneron Pharmaceuticals Inc.